Cardiovascular disease medication

Caroline E Dale, Rohan Takhar, Ray Carragher, Fatemeh Torabi, Michalis Katsoulis, Stephen Duffield, Seamus Kent, Tanja Mueller, Amanj Kurdi, Stuart McTaggart, Hoda Abbasizanjani, Sam Hollings, Andrew Scourfield, Ronan Lyons, Rowena Griffiths, Jane Lyons, Gareth Davies, Dan Harris, Alex Handy, Mehrdad Alizadeh Mizani, Chris Tomlinson, Mark Ashworth, Spiros Denaxas, Amitava Banerjee, Jonathan Sterne, Kate Lovibond, Paul Brown, Ian Bullard, Rouven Priedon, Mamas A Mamas, Ann Slee, Paula Lorgelly, Munir Pirmohamed, Kamlesh Khunti, Naveed Sattar, Andrew Morris, Cathie Sudlow, Ashley Akbari, Marion Bennie, Reecha Sofat

PH1103 / 2416 Clinical-Coded Phenotype

  1. Overview

    Phenotype Type
    Disease or syndrome
    Sex
    Both
    Valid Event Date Range
    01/04/2018 - 01/07/2021
    Coding System
    BNF codes
    Data Sources
    GPES Data for Pandemic Planning and Research (COVID-19), Prescribing Information System (PIS), Welsh Dispensing Dataset, Welsh Longitudinal General Practice Dataset (WLGP)
    Collections
    BHF Data Science CentrePhenotype Library
    Tags
    COVID-19

  2. Definition

    This study investigated the impact of the COVID-19 pandemic on non-COVID harm in 11 subpopulations, specifically the management of CVD defined by medications.

  3. Implementation

    Implementation

    No data

  4. Clinical Code List